Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Racial and Ethnic Differences in Outcomes of HCC
Clin Gastroenterol Hepatol; ePub 2018 May 31; Rich, et al
Racial/ethnic differences in outcomes of hepatocellular carcinoma (HCC) was associated with differences in detection of tumors at early stages and receipt of curative treatment among patients diagnosed with HCC, a recent study found. Researchers performed a retrospective study of patients with HCC from January 2008 through July 2017 at 2 large US health centers. They aimed to characterize racial and ethnic differences in HCC presentation, treatment, and survival. They found:
- Among the 1,117 patients with HCC (35.9% white, 34.3% black, 29.7% Hispanic), 463 (41.5%) were diagnosed with early-stage HCC and 322 underwent curative treatment.
- Hispanic and black patients were less likely to be diagnosed with early-stage HCC than white patients.
- Among those with early-stage HCC, both Hispanic and black patients were likely to undergo curative treatment vs whites.
- Black and Hispanic patients had shorter median survival times vs white patients.
- After adjustment, black patients had significantly higher mortality and Hispanic patients had lower mortality than white patients.
Rich NE, Hester C, Odewole M, et al. Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma. [Published online ahead of print May 31, 2018]. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2018.05.039.